an HBI 101 Talk
Dennis Selkoe, MD
Vincent and Stella Coates Professor of Neurologic Diseases, Harvard Medical School;
Co-Director of the Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital
After 40 years of basic research and clinical testing, the field of Alzheimer’s disease has arrived at an undersigning of the causes and mechanisms of AD, The subsequent development of therapeutic antibodies that slow AD have led to their approval in 50 countries and have proven the ‘amyloid hypothesis’ of AD, The latest antibodies appear to be particularly efficacious and safe. We are squarely in the therapeutic era of AD, thanks to intensive basic research worldwide.
Coffee and snacks will be served. We encourage all those who are able to join us in-person! However, if you can’t attend in person, a Zoom link will be provided upon registration.
A small group lunch with the speaker will follow this event. This lunch will be open to Harvard students, fellows, and research assistants and is in-person only. Please indicate on the registration form if you are interested in signing up for the lunch.